Scotiabank Initiates Coverage On Biogen with Sector Outperform Rating, Announces Price Target of $327
Portfolio Pulse from richadhand@benzinga.com
Scotiabank analyst George Farmer has initiated coverage on Biogen with a Sector Outperform rating and a price target of $327.
July 27, 2023 | 1:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biogen has received a Sector Outperform rating from Scotiabank with a price target of $327.
The initiation of coverage by Scotiabank with a Sector Outperform rating and a price target of $327 indicates a positive outlook for Biogen. This could potentially lead to an increase in investor confidence and a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100